17 Feb 2017 14:04
17 FEBRUARY 2017 Â |
Â
Â
NOTIFICATION OF INTEREST BY LEGAL & GENERAL
Â
ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that it has received notification by Legal & General Group Plc ("L&G") confirming its holding in ImmuPharma of 3,774,714 million Ordinary Shares in the capital of the Company.
Â
Full disclosure of the TR1 is shown below:
Â
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: Â | ImmuPharma Plc | |||
2. Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | Yes | |||
 An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.  | ||||
 An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments  | ||||
An event changing the breakdown of voting rights | ||||
 Other (please specify):  | ||||
3. Full name of person(s) subject to thenotification obligation: | Legal & General Group Plc (L&G) | |||
4. Full name of shareholder(s) Â (if different from 3.): | Legal & General Assurance Society Limited (LGAS) Â | |||
 5. Date of the transaction and date onwhich the threshold is crossed orreached:  | 15 February 2017 | |||
6. Date on which issuer notified: | 16 February 2017 | |||
7. Threshold(s) that is/are crossed orreached: Â | L&G (Below 3%) | |||
Â
8. Notified details: Â | ||||||||||||||||
A: Voting rights attached to shares | ||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
NumberofShares | NumberofVotingRights | Â Numberof shares | Number of votingrights | % of voting rights | ||||||||||||
Direct | Indirect | Direct | Indirect | |||||||||||||
ORD GBP 0.10 | 3,774,714 | Â Below 3% | Â Below 3% | - | Below 3% | - | ||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
 Type of financialinstrument |  Expirationdate |  Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted. |  % of votingrights | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
 Type of financialinstrument  |  Exercise price |  Expiration date |  Exercise/Conversion period |  Number of voting rights instrument refers to  |  % of voting rights  | |||||||||||
  | Nominal | Delta | ||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
  Below 3%  | ||||||||||||||||
Â
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | ||||||||||||||||||||||||||
Â
| ||||||||||||||||||||||||||
Proxy Voting: | ||||||||||||||||||||||||||
10. Name of the proxy holder: | N/A | |||||||||||||||||||||||||
11. Number of voting rights proxy holder will cease to hold: | N/A | |||||||||||||||||||||||||
12. Date on which proxy holder will cease to holdvoting rights: | N/A | |||||||||||||||||||||||||
13. Additional information: | Notification using the total voting rights figure of  124,638,362 | |||||||||||||||||||||||||
14. Contact name: | Victoria Davies (LGIM) | |||||||||||||||||||||||||
15. Contact telephone number: | 029 2035 4147 | |||||||||||||||||||||||||
Â
Â
Â
Â
Â
Â
-Ends-
Â
For further information please contact: Â
|
Â
Â
Â
Â
Â
Â